← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Renetx Bio, Inc.
New Haven, CT
$6,717,990
Total funding
4
Grants
Funding over time
peak $3M · FY2010–21$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,717,990 · 4
By mechanism
R44$3,091,078 · 1
RC3$3,000,000 · 1
U01$401,917 · 1
R41$224,995 · 1
Investigators at Renetx Bio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Axonal Growth Therapy for Neurological Recovery from Spinal Cord Injury and Strok$3,000,000
RC3 · FY2010 · NS
Clinical Evaluation of NoGo Trap Therapy in Chronic SCI$1,545,547
R44 · FY2020 · NS
Clinical Evaluation of NoGo Trap Therapy in Chronic SCI$1,545,531
R44 · FY2021 · NS
Nogo Decoy Receptor Therapy for the Treatment of Glaucoma$224,995
R41 · FY2013 · MD
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$200,958
U01 · FY2014 · AG
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$200,958
U01 · FY2013 · AG
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$1
U01 · FY2015 · AG